Micro
Emerging
Active
통합 과제는 Stride의 Q4 성과에 영향을 미칩니다.
New narrative with limited coverage — still forming.
점수
0.2
모멘텀
▲ 0.0
기사
1
출처
1
Sentiment Timeline
Event Timeline
가설
Pending
만기: 2026년 6월 23일
LRN's operating margin will contract by 150-250 basis points in Q4 2024 compared to Q4 2023 specifically attributable to integration costs and operational redundancies
Pending
만기: 2026년 7월 23일
LRN stock price will underperform S&P 500 by 8-15% in the 60 days following Q4 earnings release due to integration-related margin compression concerns
Pending
만기: 2026년 6월 23일
Stride Health (LRN) Q4 2024 revenue will decline by 5-10% year-over-year due to integration disruptions, with recovery beginning in Q1 2025
타임라인
최초 발견3월 25, 2026
최종 업데이트3월 25, 2026